In addition, miR-29c impaired the CRC cells migration and invasion abilities in vitro and cancer metastasis in vivo by directly targeting guanine nucleotide binding protein alpha13 (GNA13) and protein tyrosine phosphatase type IVA (PTP4A) [14]. Here, PTP4A2 is linked to cancer.